173 related articles for article (PubMed ID: 33107152)
1. Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
Cavalieri S; De Cecco L; Brakenhoff RH; Serafini MS; Canevari S; Rossi S; Lanfranco D; Hoebers FJP; Wesseling FWR; Keek S; Scheckenbach K; Mattavelli D; Hoffmann T; López Pérez L; Fico G; Bologna M; Nauta I; Leemans CR; Trama A; Klausch T; Berkhof JH; Tountopoulos V; Shefi R; Mainardi L; Mercalli F; Poli T; Licitra L;
Head Neck; 2021 Feb; 43(2):601-612. PubMed ID: 33107152
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
3. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning-Based MRI Radiogenomics for Evaluation of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.
Li Z; Wang R; Wang L; Tan C; Xu J; Fang J; Xian J
Acad Radiol; 2024 Jun; 31(6):2464-2475. PubMed ID: 37985290
[TBL] [Abstract][Full Text] [Related]
6. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
[TBL] [Abstract][Full Text] [Related]
7. Construction of an enhanced computed tomography radiomics model for non-invasively predicting granzyme A in head and neck squamous cell carcinoma by machine learning.
Hang R; Bai G; Sun B; Xu P; Sun X; Yan G; Zhang W; Wang F
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3353-3364. PubMed ID: 36920557
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer.
Spielvogel CP; Stoiber S; Papp L; Krajnc D; Grahovac M; Gurnhofer E; Trachtova K; Bystry V; Leisser A; Jank B; Schnoell J; Kadletz L; Heiduschka G; Beyer T; Hacker M; Kenner L; Haug AR
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):546-558. PubMed ID: 36161512
[TBL] [Abstract][Full Text] [Related]
9. Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC.
Rabasco Meneghetti A; Zwanenburg A; Linge A; Lohaus F; Grosser M; Baretton GB; Kalinauskaite G; Tinhofer I; Guberina M; Stuschke M; Balermpas P; von der Grün J; Ganswindt U; Belka C; Peeken JC; Combs SE; Böke S; Zips D; Troost EGC; Krause M; Baumann M; Löck S
Sci Rep; 2022 Oct; 12(1):16755. PubMed ID: 36202941
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
11. Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges.
Bruixola G; Remacha E; Jiménez-Pastor A; Dualde D; Viala A; Montón JV; Ibarrola-Villava M; Alberich-Bayarri Á; Cervantes A
Cancer Treat Rev; 2021 Sep; 99():102263. PubMed ID: 34343892
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of head and neck spindle cell carcinoma.
Patel AM; Choudhry HS; Desai AD; Shah VP; Patel P; Eloy JA; Roden DF; Fang CH
Head Neck; 2023 Mar; 45(3):685-696. PubMed ID: 36584171
[TBL] [Abstract][Full Text] [Related]
13. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
14. Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma.
Wang F; Zhang W; Chai Y; Wang H; Liu Z; He Y
Front Immunol; 2022; 13():1015436. PubMed ID: 36458007
[TBL] [Abstract][Full Text] [Related]
15. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
Trials; 2014 Nov; 15():469. PubMed ID: 25432788
[TBL] [Abstract][Full Text] [Related]
16. Routine surveillance scanning in HNSCC: Lung screening CT scans have value but head and neck scans do not.
Iovoli AJ; Platek AJ; Degraaff L; Wang C; Duncan WD; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Platek ME; Singh AK
Oral Oncol; 2018 Nov; 86():273-277. PubMed ID: 30409312
[TBL] [Abstract][Full Text] [Related]
17. The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
Demirci U; Coskun U; Akdemir UO; Benekli M; Kapucu O; Ozkan S; Cakir T; Baykara M; Buyukberber S
Asian Pac J Cancer Prev; 2011; 12(7):1817-20. PubMed ID: 22126572
[TBL] [Abstract][Full Text] [Related]
18. Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results.
Breheret M; Lubgan D; Haderlein M; Hecht M; Traxdorf M; Schmidt D; Müller S; Kitzsteiner C; Kuwert T; Iro H; Fietkau R; Semrau S
Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):245-254. PubMed ID: 31583430
[TBL] [Abstract][Full Text] [Related]
19. Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation.
Liu JC; Bhayani M; Kuchta K; Galloway T; Fundakowski C
Oral Oncol; 2019 Jan; 88():131-136. PubMed ID: 30616783
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
